These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24977105)

  • 1. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells.
    Hwang-Verslues WW; Lee WH; Lee EY
    J Mol Biomark Diagn; 2012; Suppl 8():6. PubMed ID: 24977105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond.
    Zhang X; Powell K; Li L
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
    Zhang R; Tu J; Liu S
    Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
    Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer stem cells as novel biomarkers.
    Ray SK; Mukherjee S
    Clin Chim Acta; 2024 Apr; 557():117855. PubMed ID: 38453050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.
    Saha T; Lukong KE
    Front Oncol; 2022; 12():856974. PubMed ID: 35392236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell in breast cancer therapeutic resistance.
    Bai X; Ni J; Beretov J; Graham P; Li Y
    Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
    Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
    Chen W; Zhang L; Liu S; Chen C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
    Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
    Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
    Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual or multiple drug loaded nanoparticles to target breast cancer stem cells.
    Gao Y; Tang M; Leung E; Svirskis D; Shelling A; Wu Z
    RSC Adv; 2020 May; 10(32):19089-19105. PubMed ID: 35518295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.
    Nguyen ST; Nguyen HL; Pham VQ; Nguyen GT; Tran CD; Phan NK; Pham PV
    Onco Targets Ther; 2015; 8():323-34. PubMed ID: 25674007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer stem cells.
    Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
    Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies.
    Romaniuk-Drapała A; Totoń E; Taube M; Idzik M; Rubiś B; Lisiak N
    Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
    Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
    Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications.
    Conde I; Ribeiro AS; Paredes J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keeping an open mind: highlights and controversies of the breast cancer stem cell theory.
    Shah M; Allegrucci C
    Breast Cancer (Dove Med Press); 2012 Oct; 4():155-66. PubMed ID: 24367202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.